| Marketing of unproven stem cell–based interventions: a call to action D Sipp, T Caulfield, J Kaye, J Barfoot, C Blackburn, S Chan, M De Luca, ... Science translational medicine 9 (397), eaag0426, 2017 | 172 | 2017 |
| Models for facilitating access to patents on genetic inventions G Van Overwalle, E Van Zimmeren, B Verbeure, G Matthijs Nature Reviews Genetics 7 (2), 143-148, 2006 | 110 | 2006 |
| Patent pools and diagnostic testing B Verbeure, E van Zimmeren, G Matthijs, G Van Overwalle TRENDS in Biotechnology 24 (3), 115-120, 2006 | 75 | 2006 |
| Trust and social capital in the design and evolution of institutions for collective action B Six, E Van Zimmeren, F Popa, C Frison International Journal of the Commons 9 (1), 2015 | 70 | 2015 |
| A clearing house for diagnostic testing: the solution to ensure access to and use of patented genetic inventions? E van Zimmeren, B Verbeure, G Matthijs, G Van Overwalle Bulletin of the World Health Organization 84, 352-359, 2006 | 58 | 2006 |
| Patent pools and clearinghouses in the life sciences E Van Zimmeren, S Vanneste, G Matthijs, W Vanhaverbeke, ... Trends in biotechnology 29 (11), 569-576, 2011 | 37 | 2011 |
| Dynamic patent governance in Europe and the United States: the Myriad example K Murray, E Van Zimmeren Cardozo J. Int'l & Comp. L. 19, 287, 2011 | 35 | 2011 |
| A paper tiger? Compulsory license regimes for public health in Europe E Van Zimmeren, G Van Overwalle International Review of Intellectual Property and Competition Law (IIC), 2011 | 31 | 2011 |
| Intellectual property ownership in coupled open innovation processes A Gorbatyuk, G Van Overwalle, E Van Zimmeren IIC-International Review of Intellectual Property and Competition Law 47 (3 …, 2016 | 21 | 2016 |
| Finding compromise on ABS & DSI in the CBD: Requirements & policy ideas from a scientific perspective AH Scholz, U Hillebrand, J Freitag, S Devanshi, C Seitz, T Thiele, ... | 19 | 2020 |
| Clearinghouse mechanisms in genetic diagnostics: conceptual framework E Van Zimmeren International Workshop Gene Patents and Clearing Models: From Concepts to …, 2006 | 19 | 2006 |
| The future role of the unified patent court in safeguarding coherence in the European patent system F Baldan, E Van Zimmeren Common Market Law Review 52 (6), 2015 | 17 | 2015 |
| Dealing with patent fragmentation in ICT and genetics: Patent pools and clearing houses G Van Overwalle, E Van Zimmeren First Monday: peer-reviewed journal on the Internet.-Chicago, Ill. 12 (6), 1-11, 2007 | 16 | 2007 |
| Bringing access and benefit sharing into the digital age S Aubry, C Frison, JC Medaglia, E Frison, M Jaspars, M Rabone, ... Plants, People, Planet 4 (1), 5-12, 2022 | 15 | 2022 |
| Functions and limits of patent law GV Overwalle, EV Zimmeren Facing the Limits of the Law, 1-28, 2009 | 11 | 2009 |
| Reshaping belgian patent law: the revision of the research exemption and the introduction of a compulsory license for public health G Van Overwalle, E Van Zimmeren Compulsory licensing: Developing economies, 168-181, 2009 | 11 | 2009 |
| Ex-officio licensing in the medical sector: the French model E Van Zimmeren, G Requena Gene patents and public health.-Brussel, 2007, 123-147, 2007 | 11 | 2007 |
| La license obligatoire belge pour raison de santé publique J Debrulle, L De Cort, M Petit, G van Overwalle, E van Zimmeren, ... Gene Patents and Public Health, 161-198, 2007 | 10 | 2007 |
| Synthetic biology and intellectual property rights: six recommendations T Minssen, B Rutz, E Van Zimmeren Biotechnology journal 10 (2), 236-241, 2015 | 9 | 2015 |
| Reshaping Belgian patent law: the revision of the research exemption and the introduction of a compulsory license for public health G Van Overwalle, E van Zimmeren Chizaiken Forum 64, 42-49, 2006 | 9 | 2006 |
